Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Or David Shahar

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Elife|February 25, 2020
Large-scale cell-type-specific imaging of protein synthesis in a vertebrate brainOr David Shahar, Erin Margaret Schuman
Frontiers in Cell and Developmental Biology|March 27, 2023
Learning and memory formation in zebrafish: Protein dynamics and molecular toolsKitty Reemst, Heba Shahin, Or David Shahar
Plos One|November 7, 2013
Acetylation of lysine 382 and phosphorylation of serine 392 in p53 modulate the interaction between p53 and MDC1 in vitroOr David Shahar, Ronen Gabizon, Oren Feine, et al.
Nucleic Acids Research|April 1, 2014
A high-throughput chemical screen with FDA approved drugs reveals that the antihypertensive drug Spironolactone impairs cancer cell survival by inhibiting homology directed repairOr David Shahar, Alkmini Kalousi, Lital Eini, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Elife|February 25, 2020
Large-scale cell-type-specific imaging of protein synthesis in a vertebrate brainOr David Shahar, Erin Margaret Schuman
Frontiers in Cell and Developmental Biology|March 27, 2023
Learning and memory formation in zebrafish: Protein dynamics and molecular toolsKitty Reemst, Heba Shahin, Or David Shahar
Plos One|November 7, 2013
Acetylation of lysine 382 and phosphorylation of serine 392 in p53 modulate the interaction between p53 and MDC1 in vitroOr David Shahar, Ronen Gabizon, Oren Feine, et al.
Nucleic Acids Research|April 1, 2014
A high-throughput chemical screen with FDA approved drugs reveals that the antihypertensive drug Spironolactone impairs cancer cell survival by inhibiting homology directed repairOr David Shahar, Alkmini Kalousi, Lital Eini, et al.
Pageof 1